(Q88733373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

title

Improvement of neurological and ocular symptoms of Behçet's disease after the introduction of infliximab (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Mirna Reihl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Mario Habek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

Nenad Vukojević

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

author name string

Branimir Anić

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

publication date

17 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

27 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

page(s)

1301-1306

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

27 March 2020

cites work

1 reference

12 December 2020

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

12 December 2020

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

1 reference

12 December 2020

Prevalence of Behçet's disease in Istanbul, Turkey.

1 reference

12 December 2020

Cytokine production profile in patients with Behcet's disease treated with infliximab

1 reference

12 December 2020

Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey.

1 reference

12 December 2020

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

1 reference

12 December 2020

Drug-induced lupus due to anti-tumor necrosis factor alpha agents

1 reference

12 December 2020

EULAR recommendations for the management of Behçet disease

1 reference

12 December 2020

Effect of infliximab in progressive neuro-Behçet's syndrome

1 reference

12 December 2020

Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration

1 reference

12 December 2020

Inflammatory demyelinating events following treatment with anti-tumor necrosis factor.

1 reference

12 December 2020

Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.

1 reference

12 December 2020

Infectious complications of tumor necrosis factor blockade

1 reference

12 December 2020

Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease

1 reference

12 December 2020

Infliximab for the treatment of refractory Adamantiades-Behçet disease with articular, intestinal, cerebral and ocular involvement

1 reference

12 December 2020

Behcet's disease: from East to West.

1 reference

12 December 2020

Successful use of infliximab in a patient with neuro-Behçet's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

1 reference

12 December 2020

Emerging drugs for uveitis

1 reference

12 December 2020

Cytokine profiles in aqueous humor of patients with different clinical entities of endogenous uveitis.

1 reference

12 December 2020

Infliximab for patients with neuro-Behcet's disease: case series and literature review.

1 reference

12 December 2020

Atypical presentation of Behçet's disease with central nervous system involvement successfully treated with infliximab

1 reference

12 December 2020

Diagnosis/Classification Criteria for Behcet's Disease

1 reference

12 December 2020

Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients

1 reference

12 December 2020

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

1 reference

12 December 2020

Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients

1 reference

12 December 2020

Case of neuro-Behçet's disease successfully maintained a remission using infliximab for 2 years

1 reference

12 December 2020

Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.

1 reference

12 December 2020

Neuro-Behçet's disease, its mimickers and anti-TNF therapy: a case-based review

1 reference

12 December 2020

Infliximab monotherapy for neuro-Behçet's disease: a case report.

1 reference

12 December 2020

Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study

1 reference

12 December 2020

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study

1 reference

12 December 2020

Infliximab is a plausible alternative for neurologic complications of Behçet disease

1 reference

12 December 2020

Anti-TNF therapy in the management of ocular attacks in an elderly patient with long-standing Behçet's disease

1 reference

12 December 2020

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

1 reference

12 December 2020

10.1007/S00296-018-4054-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29777341%20AND%20SRC:MED&resulttype=core&format=json

27 March 2020

1 reference